Cagrilintide Supplier China: Wholesale COA Guide

Resolve Cagrilintide spelling and identity

The local product slug uses cagrintide while the product name is Cagrilintide, illustrating why the RFQ must use a controlled primary name and molecular reference. Ask the supplier to confirm its spelling, identity, form and analytical target. Do not let a shortened catalog code or marketplace title substitute for the technical specification.

Compare 2mg, 5mg and 10mg units

List each requested strength separately with vial count, total nominal material, fill tolerance, available lot and units per kit. Ask whether different strengths share a parent lot and how filling genealogy is documented. MOQ may apply per strength or across a mixed order; require this distinction in writing. Do not approve silent strength substitution.

Inspect batch-specific HPLC and MS evidence

Review purity and identity data for the offered Cagrilintide lot. Check sample ID, lot, method reference, chromatogram, expected molecular information, date and report authorization. Marketplace statements such as verified or factory direct do not replace batch evidence. Confirm any third-party report with the issuing laboratory when appropriate.

Separate quantitative content from purity

A 99 percent HPLC claim cannot establish the quantity in 2mg, 5mg or 10mg vials. Require a suitable quantitative method or controlled fill record and the applicable tolerance. Confirm the mass basis used in pricing. Compare total documented material rather than only boxes or unit price.

Review stock, MOQ and repeat-lot planning

Ask whether stock is released, awaiting testing, scheduled for filling or not yet produced. Record quote validity, MOQ basis, document timing and shipping term. For repeat demand, request forecast windows, lot reservation, change notification and fresh COA approval. Actual delivery and discrepancy handling should update the supplier scorecard.

Map the supplier and batch ownership chain

Document the legal seller, manufacturing site, analytical laboratory, filling or packaging site, inventory owner and dispatch entity for the exact SKU. A supplier can coordinate qualified partners, but the arrangement and responsibilities should be transparent. Ask who releases the batch, who investigates deviations and who retains original production and test records. Require notification before a critical party changes. This supply-chain map helps buyers distinguish technical control from a generic factory claim and clarifies which company is accountable when labels, documents or received quantities do not match the approved order.

Build one comparable wholesale quotation matrix

Send every supplier the same fields: exact identity, strength, vial count, total material, target purity, identity method, quantitative-content basis, offered lot, testing status, packaging, documents, lead time and shipping term. Mark missing answers as exceptions rather than filling gaps with assumptions. Separate one-time testing or setup costs from recurring unit costs. This creates one auditable decision record for scientific, purchasing and quality reviewers and prevents the lowest-looking offer from winning simply because it describes less work.

Apply a batch-focused quality-control review

Define methods and acceptance criteria before purchase. HPLC commonly supports chromatographic purity and mass spectrometry can support identity, but neither should imply untested attributes. Check sample identifiers, dates, report numbers, units and lot relationships. Use the quality-control framework to connect each claim to evidence. Preserve original reports, record revisions and investigate contradictions before accepting the lot.

Create a documentation gate before dispatch

List the required COA, analytical attachments, SDS, specification, supported storage statement, label proof, invoice and packing list in the RFQ. Reconcile product, strength, lot, quantity and revision across documents using the documentation guide. The importer remains responsible for current destination rules. Research-use wording supports clarity but neither guarantees customs entry nor replaces destination-specific due diligence.

Qualify logistics and receiving controls

Confirm dispatch location, carrier, shipping term, packaging configuration and realistic production, release and transit windows. Reject promises of guaranteed clearance or misleading declarations. On receipt, record package condition, seals, product, strength, lot and quantity, then link internal inventory to the supplier batch. Quarantine unexplained discrepancies until a documented quality decision is completed.

Use actual performance for repeat-order approval

A controlled evaluation order should use the same specification planned for wholesale scale. Assess document accuracy, package condition, delivery time, communication and corrective response, and consider buyer-arranged testing appropriate to risk with documented sample custody. For every new lot, repeat the batch review. Require notification before changes to manufacturing, testing, filling, material specification, labels or packaging.

Related products and same-category guides

• Cagrilintide 2mg
• Cagrilintide 5mg
• Cagrilintide 10mg
• GLP-1 Research Peptide Sourcing Guide
• Tirzepatide vs Retatrutide Sourcing

Frequently asked questions